CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Barclays Assigns Overweight Rating to SAB Biotherapeutics Inc. (SABS)

Positive
AI Analysis

Summary

Barclays assigned an Overweight rating to SAB Biotherapeutics Inc. (SABS). No additional material details provided in the article.

Importance:2/10
Sentiment:
0.50
analyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on June 30, 2026 4:34 PM

Read Original